Title : Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.

Pub. Date : 2021 Apr

PMID : 33210444






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As of 2020, use of beta2-agonist salmeterol is restricted by the World Anti-Doping Agency (WADA) and is only permitted by inhalation at therapeutic doses not exceeding 200 mug in 24 h. In contrast to beta2-agonists salbutamol and formoterol, WADA has not established a urine threshold for salmeterol despite its muscle hypertrophic actions observed in animals. Formoterol Fumarate ATPase H+ transporting V0 subunit a2 Homo sapiens